The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of 5-fluorouracil (5-FU) / levofolinate / irinotecan (FOLFIRI) for previously treated advanced pancreatic cancer (APC).
 
Hiromichi Shirasu
No Relationships to Disclose
 
Takeshi Kawakami
Honoraria - Bayer Yakuhin; Chugai Pharma; Taiho Pharmaceutical; Takeda
 
Satoshi Hamauchi
No Relationships to Disclose
 
Takahiro Tsushima
Honoraria - Bayer; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Akiko Todaka
No Relationships to Disclose
 
Tomoya Yokota
Honoraria - Abbott; Bristol-Myers Squibb; Chugai Pharma; Eisai; Merck; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Japan Agency for Medical Research and Development; Merck; MSD; Pharmaceuticals and Medical Devices Agency; Rakuten Medical
Research Funding - AstraZeneca (Inst); Chugai/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly Japan (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Taiho Pharmaceutical (Inst)
 
Akira Fukutomi
Honoraria - Sawai Pharmaceutical Co; Shire; Taiho Pharmaceutical; Teijin Pharma
Research Funding - ASLAN Pharmaceuticals (Inst); Incyte (Inst); NanoCarrier (Inst); Sumitomo Dainippon (Inst); Yakult Honsha (Inst)
 
Yusuke Onozawa
Honoraria - Bayer
 
Hirofumi Yasui
No Relationships to Disclose